EnzyBase: a novel database for enzybiotic studies

详细信息    查看全文

• 作者：Hongyu Wu (1) (2)
  Hairong Lu (1) (2)
  Jinjiang Huang (1) (2)
  Guodong Li (2)
  Qingshan Huang (1) (2)
  
• 刊名：BMC Microbiology
• 出版年：2012
• 出版时间：December 2012
• 年：2012
• 卷：12
• 期：1
• 全文大小：196KB
• 参考文献：1. English BK, Gaur AH: lus-plus">The use and abuse of antibiotics and the development of antibiotic resistance. / Adv Exp Med Biol 2010, lus-plus">659:73鈥?2. CrossRef
  2. Heddini A, Cars O, Qiang S, Tomson G: lus-plus">Antibiotic resistance in China-a major future challenge. / Lancet 2009, lus-plus">373:30. CrossRef
  3. Levy SB, Marshall B: lus-plus">Antibacterial resistance worldwide: causes, challenges and responses. / Nat Med 2004, lus-plus">10:S122鈥?29. CrossRef
  4. Nelson D, Loomis L, Fischetti VA: lus-plus">Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. / Proc Natl Acad Sci USA 2001, lus-plus">98:4107鈥?112. CrossRef
  5. Veiga-Crespo P, Ageitos JM, Poza M, Villa TG: lus-plus">Enzybiotics: a look to the future, recalling the past. / J Pharm Sci 2007, lus-plus">96:1917鈥?924. CrossRef
  6. Hermoso JA, Garcia JL, Garcia P: lus-plus">Taking aim on bacterial pathogens: from phage therapy to enzybiotics. / Curr Opin Microbiol 2007, lus-plus">10:461鈥?72. CrossRef
  7. Loessner MJ: lus-plus">Bacteriophage endolysins-current state of research and applications. / Curr Opin Microbiol 2005, lus-plus">8:480鈥?87. CrossRef
  8. Fischetti VA: lus-plus">Bacteriophage lytic enzymes: novel anti-infectives. / Trends Microbiol 2005, lus-plus">13:491鈥?96. CrossRef
  9. Gordon YJ, Romanowski EG, McDermott AM: lus-plus">A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. / Curr Eye Res 2005, lus-plus">30:505鈥?15. CrossRef
  10. Borysowski J, Weber-Dabrowska B, Gorski A: lus-plus">Bacteriophage endolysins as a novel class of antibacterial agents. / Exp Biol Med (Maywood) 2006, lus-plus">231:366鈥?77.
  11. Kusuma C, Jadanova A, Chanturiya T, Kokai-Kun JF: lus-plus">Lysostaphin-resistant variants of Staphylococcus aureus demonstrate reduced fitness in vitro and in vivo. / Antimicrob Agents Chemother 2007, lus-plus">51:475鈥?82. CrossRef
  12. Bastos MdCdF, Coutinho BG, Coelho MLV: lus-plus">Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications. / pharmaceuticals 2010, lus-plus">3:1139鈥?161. CrossRef
  13. Yang G, Gao Y, Feng J, Huang Y, Li S, Liu Y, Liu C, Fan M, Shen B, Shao N: lus-plus">C-terminus of TRAP in Staphylococcus can enhance the activity of lysozyme and lysostaphin. / Acta Biochim Biophys Sin (Shanghai) 2008, lus-plus">40:452鈥?58. CrossRef
  14. Kumar JK: lus-plus">Lysostaphin: an antistaphylococcal agent. / Appl Microbiol Biotechnol 2008, lus-plus">80:555鈥?61. CrossRef
  15. Rainard P: lus-plus">Tackling mastitis in dairy cows. / Nat Biotechnol 2005, lus-plus">23:430鈥?32. CrossRef
  16. Tenovuo J: lus-plus">Clinical applications of antimicrobial host proteins lactoperoxidase, lysozyme and lactoferrin in xerostomia: efficacy and safety. / Oral Dis 2002, lus-plus">8:23鈥?9. CrossRef
  17. Donovan DM: lus-plus">Bacteriophage and peptidoglycan degrading enzymes with antimicrobial applications. / Recent Pat Biotechnol 2007, lus-plus">1:113鈥?22. CrossRef
  18. Gil-Montoya JA, Guardia-Lopez I, Gonzalez-Moles MA: lus-plus">Evaluation of the clinical efficacy of a mouthwash and oral gel containing the antimicrobial proteins lactoperoxidase, lysozyme and lactoferrin in elderly patients with dry mouth-a pilot study. / Gerodontology 2008, lus-plus">25:3鈥?. CrossRef
  19. Wang Z, Wang G: lus-plus">APD: the Antimicrobial Peptide Database. / Nucleic Acids Res 2004, lus-plus">32:D590鈥?92. CrossRef
  20. Wang G, Li X, Wang Z: lus-plus">APD2: the updated antimicrobial peptide database and its application in peptide design. / Nucleic Acids Res 2009, lus-plus">37:D933鈥?37. CrossRef
  21. Brahmachary M, Krishnan SP, Koh JL, Khan AM, Seah SH, Tan TW, Brusic V, Bajic VB: lus-plus">ANTIMIC: a database of antimicrobial sequences. / Nucleic Acids Res 2004, lus-plus">32:D586鈥?89. CrossRef
  22. Thomas S, Karnik S, Barai RS, Jayaraman VK, Idicula-Thomas S: lus-plus">CAMP: a useful resource for research on antimicrobial peptides. / Nucleic Acids Res 2010, lus-plus">38:D774鈥?80. CrossRef
  23. Hammami R, Zouhir A, Ben Hamida J, Fliss I: lus-plus">BACTIBASE: a new web-accessible database for bacteriocin characterization. / BMC Microbiol 2007, lus-plus">7:89. CrossRef
  24. Hammami R, Zouhir A, Le Lay C, Ben Hamida J, Fliss I: lus-plus">BACTIBASE second release: a database and tool platform for bacteriocin characterization. / BMC Microbiol 2010, lus-plus">10:22. CrossRef
  25. Hammami R, Ben Hamida J, Vergoten G, Fliss I: lus-plus">PhytAMP: a database dedicated to antimicrobial plant peptides. / Nucleic Acids Res 2009, lus-plus">37:963鈥?68. CrossRef
  26. Gueguen Y, Garnier J, Robert L, Lefranc MP, Mougenot I, de Lorgeril J, Janech M, Gross PS, Warr GW, Cuthbertson B, / et al.: lus-plus">PenBase, the shrimp antimicrobial peptide penaeidin database: sequence-based classification and recommended nomenclature. / Dev Comp Immunol 2006, lus-plus">30:283鈥?88. CrossRef
  27. Seebah S, Suresh A, Zhuo S, Choong YH, Chua H, Chuon D, Beuerman R, Verma C: lus-plus">Defensins knowledgebase: a manually curated database and information source focused on the defensins family of antimicrobial peptides. / Nucleic Acids Res 2007, lus-plus">35:D265鈥?68. CrossRef
  28. Wang CK, Kaas Q, Chiche L, Craik DJ: lus-plus">CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. / Nucleic Acids Res 2008, lus-plus">36:D206鈥?10. CrossRef
  29. Whitmore L, Wallace BA: lus-plus">The Peptaibol Database: a database for sequences and structures of naturally occurring peptaibols. / Nucleic Acids Res 2004, lus-plus">32:D593鈥?94. CrossRef
  30. Wu CH, Apweiler R, Bairoch A, Natale DA, Barker WC, Boeckmann B, Ferro S, Gasteiger E, Huang H, Lopez R, / et al.: lus-plus">The Universal Protein Resource (UniProt): an expanding universe of protein information. / Nucleic Acids Res 2006, lus-plus">34:D187鈥?91. CrossRef
  31. Hunter S, Apweiler R, Attwood TK, Bairoch A, Bateman A, Binns D, Bork P, Das U, Daugherty L, Duquenne L, / et al.: lus-plus">InterPro: the integrative protein signature database. / Nucleic Acids Res 2009, lus-plus">37:D211鈥?15. CrossRef
  32. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: lus-plus">The Protein Data Bank. / Nucleic Acids Res 2000, lus-plus">28:235鈥?42. CrossRef
  33. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: lus-plus">Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. / Nucleic Acids Res 1997, lus-plus">25:3389鈥?402. CrossRef
  34. Schaffer AA, Aravind L, Madden TL, Shavirin S, Spouge JL, Wolf YI, Koonin EV, Altschul SF: lus-plus">Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. / Nucleic Acids Res 2001, lus-plus">29:2994鈥?005. CrossRef
  35. Goodridge LD: lus-plus">Design of phage cocktails for therapy from a host range point of view. In / Enzybiotics: antibiotic enzymes as drugs and therapeutics. 1st edition. Edited by: Villa TG, Veiga-crespo P. New Jersey: John Wiley &Sons, Inc.,Publication; 2010:199鈥?18.
  36. Donovan DM, Dong S, Garrett W, Rousseau GM, Moineau S, Pritchard DG: lus-plus">Peptidoglycan hydrolase fusions maintain their parental specificities. / Appl Environ Microbiol 2006, lus-plus">72:2988鈥?996. CrossRef
  37. Sayle RA, Milner-White EJ: lus-plus">RASMOL: biomolecular graphics for all. / Trends Biochem Sci 1995, lus-plus">20:374. CrossRef
  
• 作者单位：Hongyu Wu (1) (2)
  Hairong Lu (1) (2)
  Jinjiang Huang (1) (2)
  Guodong Li (2)
  Qingshan Huang (1) (2)
  
  1. State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433, China
  2. Shanghai High-Tech United Bio-Technological R&D Co, Ltd, Shanghai, 201206, China
  
• ISSN：1471-2180

文摘

Background Enzybiotics are becoming increasingly recognized as potential alternative therapies for drug-resistant bacteria. Although only a few enzybiotics are currently well characterized, much information is still missing or is unavailable for researchers. The construction of an enzybiotics database would therefore increase efficiency and convenience in investigating these bioactive proteins and thus help reduce or delay the recent increase in antibiotic resistance. Description In the present manuscript, we describe the development of a novel and original database called EnzyBase, which contains 1144 enzybiotics from 216 natural sources. To ensure data quality, we limited the source of information to authoritative public databases and published scientific literature. The interface of EnzyBase is easy to use and allows users to rapidly retrieve data according to their desired search criteria and blast the database for homologous sequences. We also describe examples of database-aided enzybiotics discovery and design. Conclusion EnzyBase serves as a unique tool for enzybiotic studies. It has several potential applications, e.g. in silico enzybiotic combination as cocktails, and novel enzybiotic design, in response to continuously emerging drug-resistant pathogens. This database is a valuable platform for researchers who are interested in enzybiotic studies. EnzyBase is available online at http://biotechlab.fudan.edu.cn/database/EnzyBase/home.php.